Upload Image (Max 20MB per Image)
The US FDA has accepted ThromboGenics'biologics license application for ocriplasmin intravitreal injection,2.5mg/ml and granted it priority review. The company proposed the injection for the treatment of symptomatic Vitreomacular ...
Tags: Thrombogenics Ocriplasmin Intravitreal Injection